1. Home
  2. BWXT vs ILMN Comparison

BWXT vs ILMN Comparison

Compare BWXT & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWXT
  • ILMN
  • Stock Information
  • Founded
  • BWXT 1867
  • ILMN 1998
  • Country
  • BWXT United States
  • ILMN United States
  • Employees
  • BWXT N/A
  • ILMN N/A
  • Industry
  • BWXT
  • ILMN Medical Specialities
  • Sector
  • BWXT
  • ILMN Health Care
  • Exchange
  • BWXT Nasdaq
  • ILMN Nasdaq
  • Market Cap
  • BWXT 12.8B
  • ILMN 13.1B
  • IPO Year
  • BWXT N/A
  • ILMN 2000
  • Fundamental
  • Price
  • BWXT $137.04
  • ILMN $99.25
  • Analyst Decision
  • BWXT Buy
  • ILMN Buy
  • Analyst Count
  • BWXT 9
  • ILMN 17
  • Target Price
  • BWXT $138.83
  • ILMN $124.35
  • AVG Volume (30 Days)
  • BWXT 1.4M
  • ILMN 2.4M
  • Earning Date
  • BWXT 08-04-2025
  • ILMN 07-31-2025
  • Dividend Yield
  • BWXT 0.73%
  • ILMN N/A
  • EPS Growth
  • BWXT 13.77
  • ILMN N/A
  • EPS
  • BWXT 3.14
  • ILMN N/A
  • Revenue
  • BWXT $2,781,946,000.00
  • ILMN $4,337,000,000.00
  • Revenue This Year
  • BWXT $15.44
  • ILMN N/A
  • Revenue Next Year
  • BWXT $9.29
  • ILMN $3.15
  • P/E Ratio
  • BWXT $43.65
  • ILMN N/A
  • Revenue Growth
  • BWXT 9.88
  • ILMN N/A
  • 52 Week Low
  • BWXT $84.21
  • ILMN $68.70
  • 52 Week High
  • BWXT $145.33
  • ILMN $156.66
  • Technical
  • Relative Strength Index (RSI)
  • BWXT 53.14
  • ILMN 65.51
  • Support Level
  • BWXT $133.84
  • ILMN $95.09
  • Resistance Level
  • BWXT $144.58
  • ILMN $101.28
  • Average True Range (ATR)
  • BWXT 3.38
  • ILMN 3.28
  • MACD
  • BWXT -1.66
  • ILMN 0.10
  • Stochastic Oscillator
  • BWXT 29.33
  • ILMN 78.82

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales primarily in the United States, Canada, and other regions.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: